These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
566 related articles for article (PubMed ID: 21480217)
1. Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells. Kryczek I; Liu S; Roh M; Vatan L; Szeliga W; Wei S; Banerjee M; Mao Y; Kotarski J; Wicha MS; Liu R; Zou W Int J Cancer; 2012 Jan; 130(1):29-39. PubMed ID: 21480217 [TBL] [Abstract][Full Text] [Related]
2. Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival. Silva IA; Bai S; McLean K; Yang K; Griffith K; Thomas D; Ginestier C; Johnston C; Kueck A; Reynolds RK; Wicha MS; Buckanovich RJ Cancer Res; 2011 Jun; 71(11):3991-4001. PubMed ID: 21498635 [TBL] [Abstract][Full Text] [Related]
3. ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma. Kim MP; Fleming JB; Wang H; Abbruzzese JL; Choi W; Kopetz S; McConkey DJ; Evans DB; Gallick GE PLoS One; 2011; 6(6):e20636. PubMed ID: 21695188 [TBL] [Abstract][Full Text] [Related]
5. Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Ma S; Chan KW; Lee TK; Tang KH; Wo JY; Zheng BJ; Guan XY Mol Cancer Res; 2008 Jul; 6(7):1146-53. PubMed ID: 18644979 [TBL] [Abstract][Full Text] [Related]
6. Expression of CD133 and CD117 in 64 Serous Ovarian Cancer Cases. Stemberger-Papić S; Vrdoljak-Mozetic D; Ostojić DV; Rubesa-Mihaljević R; Krigtofić I; Brncić-Fisher A; Kragević M; Eminović S Coll Antropol; 2015 Sep; 39(3):745-53. PubMed ID: 26898076 [TBL] [Abstract][Full Text] [Related]
7. CD133 expression defines a tumor initiating cell population in primary human ovarian cancer. Curley MD; Therrien VA; Cummings CL; Sergent PA; Koulouris CR; Friel AM; Roberts DJ; Seiden MV; Scadden DT; Rueda BR; Foster R Stem Cells; 2009 Dec; 27(12):2875-83. PubMed ID: 19816957 [TBL] [Abstract][Full Text] [Related]
8. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Bertolini G; Roz L; Perego P; Tortoreto M; Fontanella E; Gatti L; Pratesi G; Fabbri A; Andriani F; Tinelli S; Roz E; Caserini R; Lo Vullo S; Camerini T; Mariani L; Delia D; Calabrò E; Pastorino U; Sozzi G Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16281-6. PubMed ID: 19805294 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: relationships with markers of tumor hypoxia and microvascularity. Currie MJ; Beardsley BE; Harris GC; Gunningham SP; Dachs GU; Dijkstra B; Morrin HR; Wells JE; Robinson BA Hum Pathol; 2013 Mar; 44(3):402-11. PubMed ID: 23036368 [TBL] [Abstract][Full Text] [Related]
10. Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics. Calcagno AM; Salcido CD; Gillet JP; Wu CP; Fostel JM; Mumau MD; Gottesman MM; Varticovski L; Ambudkar SV J Natl Cancer Inst; 2010 Nov; 102(21):1637-52. PubMed ID: 20935265 [TBL] [Abstract][Full Text] [Related]
11. Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors. Rutella S; Bonanno G; Procoli A; Mariotti A; Corallo M; Prisco MG; Eramo A; Napoletano C; Gallo D; Perillo A; Nuti M; Pierelli L; Testa U; Scambia G; Ferrandina G Clin Cancer Res; 2009 Jul; 15(13):4299-311. PubMed ID: 19509143 [TBL] [Abstract][Full Text] [Related]
12. The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer. Tirino V; Camerlingo R; Franco R; Malanga D; La Rocca A; Viglietto G; Rocco G; Pirozzi G Eur J Cardiothorac Surg; 2009 Sep; 36(3):446-53. PubMed ID: 19464919 [TBL] [Abstract][Full Text] [Related]
13. Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3. Ma L; Lai D; Liu T; Cheng W; Guo L Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):593-602. PubMed ID: 20705681 [TBL] [Abstract][Full Text] [Related]
14. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers. Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682 [TBL] [Abstract][Full Text] [Related]
15. Cancer stem-like cells of ovarian clear cell carcinoma are enriched in the ALDH-high population associated with an accelerated scavenging system in reactive oxygen species. Mizuno T; Suzuki N; Makino H; Furui T; Morii E; Aoki H; Kunisada T; Yano M; Kuji S; Hirashima Y; Arakawa A; Nishio S; Ushijima K; Ito K; Itani Y; Morishige K Gynecol Oncol; 2015 May; 137(2):299-305. PubMed ID: 25541259 [TBL] [Abstract][Full Text] [Related]
16. CD133+ ovarian cancer stem-like cells promote non-stem cancer cell metastasis via CCL5 induced epithelial-mesenchymal transition. Long H; Xiang T; Qi W; Huang J; Chen J; He L; Liang Z; Guo B; Li Y; Xie R; Zhu B Oncotarget; 2015 Mar; 6(8):5846-59. PubMed ID: 25788271 [TBL] [Abstract][Full Text] [Related]
17. Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery. Fang DD; Kim YJ; Lee CN; Aggarwal S; McKinnon K; Mesmer D; Norton J; Birse CE; He T; Ruben SM; Moore PA Br J Cancer; 2010 Apr; 102(8):1265-75. PubMed ID: 20332776 [TBL] [Abstract][Full Text] [Related]
18. Cancer stem-like cells in human prostate carcinoma cells DU145: the seeds of the cell line? Wei C; Guomin W; Yujun L; Ruizhe Q Cancer Biol Ther; 2007 May; 6(5):763-8. PubMed ID: 17592251 [TBL] [Abstract][Full Text] [Related]
19. [Isolation and identification of cancer stem cells from primary human ovarian cancer tissues]. Lin S; Long HX; Xiang T; Zhu B; Xie RK Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):896-9. PubMed ID: 22340097 [TBL] [Abstract][Full Text] [Related]
20. Chemoresistance of CD133+ cancer stem cells in laryngeal carcinoma. Yang JP; Liu Y; Zhong W; Yu D; Wen LJ; Jin CS Chin Med J (Engl); 2011 Apr; 124(7):1055-60. PubMed ID: 21542968 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]